Eklöf B
Straub Clinic and Hospital, Honolulu, Hawaii 96813.
Cardiovasc Surg. 1994 Apr;2(2):187-94.
Charles Rob and the vascular surgeons at Strong Memorial Hospital have made significant contributions to the development of venology. Their impact on the surgical treatment of venous thromboembolism is emphasized. The technique for thrombectomy with temporary arteriovenous fistula is described. In a prospective randomized study from Sweden iliac vein patency was found in 76% of the operated group and 35% of the conservatively treated group after 6 months, and 77% versus 30%, respectively, after 5 years. A patent femoropopliteal vein with competent valves was found in 52% of the surgically treated patients compared with 26% of those treated conservatively after 6 months, and 36% versus 11%, respectively, after 5 years. Thrombectomy with temporary arteriovenous fistula is the author's method of choice to treat patients with acute iliofemoral venous thrombosis if the history of swelling of the thigh indicating iliac vein obstruction is less than 7 days' duration and the activity expectancy of the patient is more than 10 years.
查尔斯·罗布（Charles Rob）以及斯特朗纪念医院的血管外科医生们为静脉学的发展做出了重大贡献。文中强调了他们对静脉血栓栓塞症外科治疗的影响。描述了采用临时性动静脉瘘进行血栓切除术的技术。在瑞典的一项前瞻性随机研究中，术后6个月，手术组髂静脉通畅率为76%，保守治疗组为35%；5年后，分别为77%和30%。术后6个月，接受手术治疗的患者中52%的股腘静脉通畅且瓣膜功能良好，而保守治疗的患者中这一比例为26%；5年后，分别为36%和11%。如果大腿肿胀病史提示髂静脉阻塞的持续时间少于7天且患者预期寿命超过10年，采用临时性动静脉瘘进行血栓切除术是作者治疗急性髂股静脉血栓形成患者的首选方法。
